Related Experiment Video
Updated: Jul 19, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Postpartum choriocarcinoma presentation, management and survival
David Nugent1, Ayman Hassadia, Jan Everard
1Department of Gynaecological Oncology, Royal Hallamshire Hospital, Sheffield, UK.
The Journal of Reproductive Medicine
|November 8, 2006
Summary
Postpartum choriocarcinoma often presents as persistent vaginal bleeding, with diagnosis frequently delayed. Early recognition and treatment are crucial for favorable outcomes, though advanced cases, particularly with brain metastases, carry a fatal risk.
Area of Science:
- Gynecology
- Oncology
- Reproductive Medicine
Background:
- Postpartum choriocarcinoma is a rare but serious complication following pregnancy.
- Timely diagnosis and treatment are critical for patient survival and management.
Purpose of the Study:
- To investigate the clinical presentation and treatment outcomes of postpartum choriocarcinoma.
- To identify factors influencing diagnosis and prognosis in these patients.
Main Methods:
- A retrospective case note review was conducted.
- Data from 35 patients treated at the Sheffield Trophoblastic Disease Centre between 1977 and 2005 were analyzed.
Main Results:
- The majority of patients (33/35) presented with persistent postpartum hemorrhage.
- A significant delay in diagnosis was observed, averaging 7 weeks postpartum.
- Twenty patients had metastatic disease; however, survival rates were generally favorable with a mean of 7.8 years, though two deaths occurred.
Conclusions:
- Postpartum choriocarcinoma predominantly manifests as vaginal bleeding, often with diagnostic delays.
- While most cases respond to treatment, particularly low-risk ones with methotrexate, symptomatic brain metastases are associated with a poor prognosis.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...